TY - JOUR
T1 - OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions
T2 - a scoping review to identify candidate instruments
AU - Naye, Florian
AU - Toupin-April, Karine
AU - de Wit, Maarten
AU - LeBlanc, Annie
AU - Dubois, Olivia
AU - Boonen, Annelies
AU - Barton, Jennifer L
AU - Fraenkel, Liana
AU - Li, Linda C
AU - Stacey, Dawn
AU - March, Lyn
AU - Barber, Claire E H
AU - Hazlewood, Glen Stewart
AU - Guillemin, Francis
AU - Bartlett, Susan J
AU - Berthelsen, Dorthe B
AU - Mather, Kate
AU - Arnaud, Laurent
AU - Akpabio, Akpabio
AU - Adebajo, Adewale
AU - Schultz, Grayson
AU - Sloan, Victor S
AU - Gill, Tiffany K
AU - Sharma, Saurab
AU - Scholte-Voshaar, Marieke
AU - Caso, Francesco
AU - Nikiphorou, Elena
AU - Nasef, Samah Ismail
AU - Campbell, Willemina
AU - Meara, Alexa
AU - Christensen, Robin
AU - Suarez-Almazor, Maria E
AU - Jull, Janet Elizabeth
AU - Alten, Rieke
AU - Morgan, Esi M
AU - El-Miedany, Yasser
AU - Singh, Jasvinder A
AU - Burt, Jennifer
AU - Jayatilleke, Arundathi
AU - Hmamouchi, Ihsane
AU - Blanco, Francisco J
AU - Fernandez, Anthony P
AU - Mackie, Sarah
AU - Jones, Allyson
AU - Strand, Vibeke
AU - Monti, Sara
AU - Stones, Simon R
AU - Lee, Rebecca R
AU - Nielsen, Sabrina Mai
AU - Evans, Vicki
AU - Srinivasalu, Hemalatha
AU - Gérard, Thomas
AU - Demers, Juliette LeBlanc
AU - Bouchard, Roxanne
AU - Stefan, Théo
AU - Dugas, Michèle
AU - Bergeron, Frédéric
AU - Beaton, Dorcas
AU - Maxwell, Lara J
AU - Tugwell, Peter
AU - Décary, Simon
N1 - Copyright © 2023 Elsevier Inc. All rights reserved.
PY - 2024/4
Y1 - 2024/4
N2 - OBJECTIVES: Shared decision making (SDM) is a central tenet in rheumatic and musculoskeletal care. The lack of standardization regarding SDM instruments and outcomes in clinical trials threatens the comparative effectiveness of interventions. The Outcome Measures in Rheumatology (OMERACT) SDM Working Group is developing a Core Outcome Set for trials of SDM interventions in rheumatology and musculoskeletal health. The working group reached consensus on a Core Outcome Domain Set in 2020. The next step is to develop a Core Outcome Measurement Set through the OMERACT Filter 2.2.METHODS: We conducted a scoping review (PRISMA-ScR) to identify candidate instruments for the OMERACT Filter 2.2 We systematically reviewed five databases (Ovid MEDLINE®, Embase, Cochrane Library, CINAHL and Web of Science). An information specialist designed search strategies to identify all measurement instruments used in SDM studies in adults or children living with rheumatic or musculoskeletal diseases or their important others. Paired reviewers independently screened titles, abstracts, and full text articles. We extracted characteristics of all candidate instruments (e.g., measured construct, measurement properties). We classified candidate instruments and summarized evidence gaps with an adapted version of the Summary of Measurement Properties (SOMP) table.RESULTS: We found 14,464 citations, read 239 full text articles, and included 99 eligible studies. We identified 220 potential candidate instruments. The five most used measurement instruments were the Decisional Conflict Scale (traditional and low literacy versions) (n=38), the Hip/Knee-Decision Quality Instrument (n=20), the Decision Regret Scale (n=9), the Preparation for Decision Making Scale (n=8), and the CollaboRATE (n=8). Only 44 candidate instruments (20%) had any measurement properties reported by the included studies. Of these instruments, only 57% matched with at least one of the 7-criteria adapted SOMP table.CONCLUSION: We identified 220 candidate instruments used in the SDM literature amongst people with rheumatic and musculoskeletal diseases. Our classification of instruments showed evidence gaps and inconsistent reporting of measurement properties. The next steps for the OMERACT SDM Working Group are to match candidate instruments with Core Domains, assess feasibility and review validation studies of measurement instruments in rheumatic diseases or other conditions. Development and validation of new instruments may be required for some Core Domains.
AB - OBJECTIVES: Shared decision making (SDM) is a central tenet in rheumatic and musculoskeletal care. The lack of standardization regarding SDM instruments and outcomes in clinical trials threatens the comparative effectiveness of interventions. The Outcome Measures in Rheumatology (OMERACT) SDM Working Group is developing a Core Outcome Set for trials of SDM interventions in rheumatology and musculoskeletal health. The working group reached consensus on a Core Outcome Domain Set in 2020. The next step is to develop a Core Outcome Measurement Set through the OMERACT Filter 2.2.METHODS: We conducted a scoping review (PRISMA-ScR) to identify candidate instruments for the OMERACT Filter 2.2 We systematically reviewed five databases (Ovid MEDLINE®, Embase, Cochrane Library, CINAHL and Web of Science). An information specialist designed search strategies to identify all measurement instruments used in SDM studies in adults or children living with rheumatic or musculoskeletal diseases or their important others. Paired reviewers independently screened titles, abstracts, and full text articles. We extracted characteristics of all candidate instruments (e.g., measured construct, measurement properties). We classified candidate instruments and summarized evidence gaps with an adapted version of the Summary of Measurement Properties (SOMP) table.RESULTS: We found 14,464 citations, read 239 full text articles, and included 99 eligible studies. We identified 220 potential candidate instruments. The five most used measurement instruments were the Decisional Conflict Scale (traditional and low literacy versions) (n=38), the Hip/Knee-Decision Quality Instrument (n=20), the Decision Regret Scale (n=9), the Preparation for Decision Making Scale (n=8), and the CollaboRATE (n=8). Only 44 candidate instruments (20%) had any measurement properties reported by the included studies. Of these instruments, only 57% matched with at least one of the 7-criteria adapted SOMP table.CONCLUSION: We identified 220 candidate instruments used in the SDM literature amongst people with rheumatic and musculoskeletal diseases. Our classification of instruments showed evidence gaps and inconsistent reporting of measurement properties. The next steps for the OMERACT SDM Working Group are to match candidate instruments with Core Domains, assess feasibility and review validation studies of measurement instruments in rheumatic diseases or other conditions. Development and validation of new instruments may be required for some Core Domains.
KW - Adult
KW - Child
KW - Humans
KW - Decision Making, Shared
KW - Rheumatic Diseases/therapy
KW - Rheumatology
KW - Outcome Assessment, Health Care
KW - Consensus
UR - http://www.scopus.com/inward/record.url?scp=85182679800&partnerID=8YFLogxK
M3 - Review
C2 - 38232625
SN - 0049-0172
VL - 65
SP - 152344
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
M1 - 152344
ER -